The Significance of Colocalization of Plasminogen Activator Inhibitor-1 and Vitronectin in Hepatic Fibrosis
Sadataka Inuzuka, Ken Tanikawa(Kurume University), Ryuichiro Sakata(Kurume University), Nobuhide Kusaba(Kurume University), Takato Ueno(Kurume University), Hiroshi Sugawara(Kurume University), M Sata(Keio University), S. Tamaki(Kurume University), Takuji Torimura(Omuta hospital)
Cited by 22
Related Papers
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
|Liver International|2020|410